Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4-((2,2-dimethyl-1-oxopropyl)amino)butanoic Acid
2. N-trimethylacetyl Gaba
3. N-trimethylacetyl-4-aminobutyric Acid
4. Pivagabin
5. Tonerg
1. 69542-93-4
2. 4-pivalamidobutanoic Acid
3. 4-[(2,2-dimethylpropanoyl)amino]butanoic Acid
4. Cxb-722
5. Pivagabine [inn]
6. 4-(2,2-dimethylpropanoylamino)butanoic Acid
7. Cxb722
8. 4-pivalamidobutyric Acid
9. C53sv0wo4v
10. Pivagabine (inn)
11. 4-(2,2-dimethylpropionylamino)butyric Acid
12. Ncgc00160457-01
13. Dsstox_cid_26162
14. Dsstox_rid_81393
15. Dsstox_gsid_46162
16. Tonerg
17. Cas-69542-93-4
18. 4-pivalamidobutanoicacid
19. Sr-01000945179
20. N-trimethylacetyl-4-aminobutyric Acid
21. Unii-c53sv0wo4v
22. Einecs 274-038-3
23. 4-(2,2-dimethylpropanamido)butanoic Acid
24. 4-pivalamido-butyric Acid
25. Pivagabine [mart.]
26. Pivagabine [who-dd]
27. Schembl96152
28. Butyric Acid, 4-pivalamido-
29. N-pivaloyl-4-aminobutyric Acid
30. Chembl1870796
31. Dtxsid3046162
32. Niosh/et6170000
33. Chebi:134834
34. Act10073
35. Zinc1545856
36. Tox21_111827
37. Mfcd00868454
38. Akos000127419
39. Tox21_111827_1
40. Db12951
41. Ncgc00160457-02
42. Da-18317
43. Hy-108295
44. 4- (2,2-dimethylpropionylamino)butyric Acid
45. Cs-0028165
46. Et61700000
47. Ft-0744708
48. 4-((2,2-dimethylpropionyl)amino)butyric Acid
49. En300-27463
50. D07342
51. A866811
52. J-514186
53. Q7199622
54. Sr-01000945179-1
55. Sr-01000945179-2
56. Z85888809
57. Butanoic Acid, 4-((2,2-dimethyl-1-oxopropyl)amino)-
| Molecular Weight | 187.24 g/mol |
|---|---|
| Molecular Formula | C9H17NO3 |
| XLogP3 | 0.8 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 5 |
| Exact Mass | 187.12084340 g/mol |
| Monoisotopic Mass | 187.12084340 g/mol |
| Topological Polar Surface Area | 66.4 Ų |
| Heavy Atom Count | 13 |
| Formal Charge | 0 |
| Complexity | 194 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
N - Nervous system
N06 - Psychoanaleptics
N06A - Antidepressants
N06AX - Other antidepressants
N06AX15 - Pivagabine
Digital Content 
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Pivagabine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pivagabine, including repackagers and relabelers. The FDA regulates Pivagabine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pivagabine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Pivagabine supplier is an individual or a company that provides Pivagabine active pharmaceutical ingredient (API) or Pivagabine finished formulations upon request. The Pivagabine suppliers may include Pivagabine API manufacturers, exporters, distributors and traders.
click here to find a list of Pivagabine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Pivagabine DMF (Drug Master File) is a document detailing the whole manufacturing process of Pivagabine active pharmaceutical ingredient (API) in detail. Different forms of Pivagabine DMFs exist exist since differing nations have different regulations, such as Pivagabine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Pivagabine DMF submitted to regulatory agencies in the US is known as a USDMF. Pivagabine USDMF includes data on Pivagabine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Pivagabine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Pivagabine suppliers with USDMF on PharmaCompass.
Pivagabine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pivagabine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pivagabine GMP manufacturer or Pivagabine GMP API supplier for your needs.
A Pivagabine CoA (Certificate of Analysis) is a formal document that attests to Pivagabine's compliance with Pivagabine specifications and serves as a tool for batch-level quality control.
Pivagabine CoA mostly includes findings from lab analyses of a specific batch. For each Pivagabine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pivagabine may be tested according to a variety of international standards, such as European Pharmacopoeia (Pivagabine EP), Pivagabine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pivagabine USP).
LOOKING FOR A SUPPLIER?
